These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26632549)

  • 21. [A study of interleukin-10 gene polymorphisms in Miao, Dong and Buyi ethnics of Guizhou].
    Wang CJ; Shan KR; He Y; Zhang T; Li Y; Wu CX; Zhang C; Guan ZZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):116-20. PubMed ID: 23450495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Y-SNP analysis of Bouyei, Gelao, Mulao, Maonan, and Zhuang populations in Guizhou].
    Liu X; Shan KR; Qi XL; He Y; Zhao Y; Wu CX; Li Y; Chu X; Ren XL
    Yi Chuan; 2006 Nov; 28(11):1350-4. PubMed ID: 17098700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forensic genetic polymorphisms of 16 X-STR loci in the Yunnan Miao population and their relationship to other Chinese groups.
    Zhang X; Yuan X; Huang Y; Yao J; Zhang J; Dai J; Liu L; Nie S; Hu L
    Leg Med (Tokyo); 2021 Nov; 53():101961. PubMed ID: 34479066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.
    Jin T; Shi X; Wang L; Wang H; Feng T; Kang L
    BMC Genet; 2016 May; 17(1):70. PubMed ID: 27233804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive whole genome database of ethnic minority populations.
    He Y; Lei C; Wan C; Zeng S; Zhang T; Luo F; Li R; Li X; Zhao A; Xiao D; Luo Y; Shan K; Qi X; Jin X
    Sci Rep; 2024 Jun; 14(1):13954. PubMed ID: 38886537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism of pharmacogenomic VIP variants in the Deng people from the Himalayas in Southeast Tibet.
    Shi X; Wang L; Du S; Wang H; Feng T; Jin T; Kang L
    Biomarkers; 2015; 20(5):275-86. PubMed ID: 26329523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province.
    Zhang C; Jiang X; Chen W; Li Q; Yun F; Yang X; Dai R; Cheng Y
    Medicine (Baltimore); 2018 Dec; 97(52):e13674. PubMed ID: 30593137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation of pharmacogenomic VIP variants in Zhuang nationality of southern China.
    Liu Y; Li H; Cao K; Liu J; Sun Y; Wu J; Xiong Z; Niu F; Li J; Jin T
    Pharmacogenomics J; 2021 Feb; 21(1):60-68. PubMed ID: 32699276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic diversity, structure and forensic characteristics of Hmong-Mien-speaking Miao revealed by autosomal insertion/deletion markers.
    Zhang H; He G; Guo J; Ren Z; Zhang H; Wang Q; Ji J; Yang M; Huang J; Wang CC
    Mol Genet Genomics; 2019 Dec; 294(6):1487-1498. PubMed ID: 31312894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic distribution analyses and population background explorations of Gansu Yugur and Guizhou Miao groups via InDel markers.
    Yang CH; Jin XY; Guo YX; Cui W; Chen C; Meng HT; Zhu BF
    J Hum Genet; 2019 Jun; 64(6):535-543. PubMed ID: 30944401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province.
    Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into AIM-InDel diversities in Yunnan Miao and Hani ethnic groups of China for forensic and population genetic purposes.
    Cui W; Nie S; Fang Y; Chen M; Zhao M; Lan Q; Shen C; Zhu B
    Hereditas; 2022 May; 159(1):22. PubMed ID: 35590349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5, 10-methylenetetrahydrofolate reductase polymorphism in three nationalities of Guizhou in China].
    Xiao Y; Shan K; Li Y; Zhao Y; Qi X; Xie Y; Wu C; Ma J; Liu H; Xu Y; Guan Z; Ren X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):219-21. PubMed ID: 15793792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Circassian Subpopulation from Jordan.
    Al-Eitan LN; Mohammad NN; Al-Maqableh HW; Hakooz NM; Dajani RB
    Curr Drug Metab; 2019; 20(8):674-681. PubMed ID: 31362667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.
    Chen C; Li S; Lu X; Tan B; Huang C; Qin L
    Int J Clin Exp Pathol; 2014; 7(5):2558-64. PubMed ID: 24966969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of very important pharmacogene variants in the Tibetan population from China.
    Rong H; Dong H; He X; Yuan D; Bai M; Wang L; Liu T; He Y; Zheng J; Wang Y; Jin T
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):668-678. PubMed ID: 32311112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VKORC1 haplotypes in five East-Asian populations and Indians.
    Lee MT; Chen CH; Chuang HP; Lu LS; Chou CH; Chen YT; Liu CY; Wen MS; Lu JJ; Chang CF; Wu JY; Chen YT
    Pharmacogenomics; 2009 Oct; 10(10):1609-16. PubMed ID: 19842934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-A, -B, and -DRB1 gene polymorphism in the Miao ethnic group of Hunan, China.
    Qian X; Xie Y; Lu G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):277-85. PubMed ID: 20448347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.